- A preview of this full-text is provided by Wiley.
- Learn more
Preview content only
Content available from Journal of Food Biochemistry
This content is subject to copyright. Terms and conditions apply.
J Food Biochem. 2019;43:e12986. wileyonlinelibrary.com/journal/jfbc
|
1 of 17
https://doi.org/10.1111/jc.12986
© 2019 Wiley Periodicals, Inc.
Received:11March2019
|
Revised:27J une2019
|
Accepted:30June2019
DOI: 10.1111/jfbc .12986
FULL ARTICLE
Dietary chia seeds (Salvia hispanica) improve acute dyslipidemia
and steatohepatitis in rats
Eduardo Fernández‐Martínez1 | Ivet G. Lira‐Islas1 | Raquel Cariño‐Cortés1 |
Luis E. Soria‐Jasso1 | Elizabeth Pérez‐Hernández2 | Nury Pérez‐Hernández3
1Laboratory of Medicinal Chemistr y and
Pharmacology, Centro de Investigación
en Biología de la Reproducción, Área
AcadémicadeMedicina,Institutode
CienciasdelaSalud,UniversidadAutónoma
delEstadodeHidalgo,Pachuca,México
2Hospital de Ortopedia “Dr. Victorio de la
FuenteNar váez”,IMSS,CiudaddeMéxico,
México
3Programa Institucional de Biomedicina
Molecular, Escuela Nacional de Medicina y
Homeopatía,InstitutoPolitécnicoNacional,
CiudaddeMéxico,México
Correspondence
Eduardo Fernández‐Martínez, Laboratory
of Medicinal Chemistry and Pharmacology.
Centro de Investigación en Biología de la
Reproducción,ÁreaAcadémicadeMedicina,
Instituto de Ciencias de la Salud, Universidad
AutónomadelEstadodeHidalgo.C alleDr.
Eliseo Ramírez Ulloa no. 400, Col. Doctores,
PachucaHidalgo,42090,México.
Emails:efernan@uaeh.edu.mx,tomedyfm@
hotmail.com
Funding information
UniversidadAutónomadelEstadode
Hidalgo,Grant/AwardNumber:PAI-UAEH,
keyDI-IC SA-MED-SF-046,projectnumber3
Abstract
Chia seeds (Salvia hispanica L.) are rich in omega fatty acids. Dyslipidemia and
steatohepatitis are diseases that require effective treatments in obese and non‐obese
patients.Theaimwas toevaluatetheeffectofchiaintakeon acutetyloxapol(TI)-
induced dyslipidemia, on acute carbon tetrachloride (TC)‐induced steatohepatitis,
andonmixeddamage(TC+TI)innon-obeserats.Fourexperimentalgroupswerefed
for 4 weeks a diet with established rodent food (DE), and four groups were fed a
diet with 15% added chia (DC). Plasma samples were analyzed for total cholesterol,
triglycerides, glucose, biochemical liver damage markers, and tumor necrosis factor‐α
(TNF‐α).Liversampleswereusedtoquantify glycogen,catalase,lipidperoxidation,
and TNF‐α. A histopathological analysis was performed. DC intake partially or
totally prevented steatohepatitis, and reduced lipids in the dyslipidemic groups. The
hypolipidemic and hepatoprotective effects of chia may be correlated to its high
content of α‐linolenic acid (omega‐3) and phenolics.
Practical applications
Metabolicsyndromeisassociatedwithnon-alcoholicfattyliverdisease(NAFLD)and
non-alcoholicsteatohepatitis(NASH),whicharecurrentlythemost common causes
of chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC) worldwide.
Dyslipidemia is a significant risk factor forNAFLD and NASH. Non-obese patients
mayhaveNAFLDorNASH.Metabolicsyndromeanddyslipidemiaaremorestrongly
associatedwith NAFLD innon-obese thanin obesepatients.This is the first study
evaluating the hypolipidemic and hepatoprotective effects of chia seed intake on
acute dyslipidemia and/or steatohepatitis caused by the individual or combined
administration of the inducers tyloxapol and carbon tetrachloride, respectively, in
non‐obese rats. The pharmacological effects of dietary chia are correlated to its high
content of omega‐3 and omega‐6 (1:1), protein, dietary fiber, and phenolics. The results
suggest that inclusion of chia in diets of non‐obese patients with dyslipidemia and/or
NAFLD/NASHmayimprovetheirhealthstateandpreventingcirrhosisorHCC.
KEYWORDS
chia, dyslipidemia, fatty acids, fatty liver, omega‐3, steatohepatitis